December 10, 2004
Supreme Court Declines to Hear Rochester's Appeal in High-Stakes Patent Case
By GOLDIE BLUMENSTYKThe University of Rochester's costly uphill battle to win billions of dollars in a patent-infringement lawsuit involving the popular anti-inflammatory drugs Celebrex and Bextra ended last week, when the U.S. Supreme Court announced that it would not consider the university's appeal.
The Supreme Court's decision leaves intact a 2003 ruling by a federal court that had found the university's patent invalid.
"It's a great disappointment,"
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
